article thumbnail

Financial factors to support and challenge Pharma in 2024

European Pharmaceutical Review

According to results from a survey by GlobalData, the top challenges for the pharmaceutical industry in 2024 will be inflation, geopolitical conflict and drug pricing pressures. Data outcomes revealed that most respondents from Pharma considered that drug pricing and reimbursement constraints will have a negative impact in 2024.

article thumbnail

Why CG Oncology will be the first test of 2024’s IPO waters

STAT

Damian here with an in-depth preview of a certain annual biotech conference, a look at the cutting edge of obesity drug development, and year’s first IPO filing.   Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Read the rest…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

From digital twins to health equity: Nine healthcare trends shaking up 2024

Definitive Healthcare

Resource Type E-Books & How-To Guides Blog How-To Guide Healthcare Insight Medical claims 101: What you need to know How to sell effectively to healthcare facilities and executives using the right… Hospital payor mix by state Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToShow":2,

article thumbnail

Novavax is on thin ice, and the latest update isn’t exactly encouraging

STAT

On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 Biotech can’t shake the Fed The XBI, a closely watched index of biotech stocks, turned red for the year yesterday, and not because of a clinical disappointment, a drug pricing scandal, or an M&A rumor that came to nothing.

article thumbnail

The highs — and lows — of JPM 2024 you should pay attention to

STAT

JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations. In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout.

article thumbnail

This is the TLDR of JPM Day 1

STAT

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference, join our newsletter list. “The lanyards” have landed! Morgan Healthcare Conference.

article thumbnail

October 2023 Newsletter

Safe Biologics

Learn about ASBM’s recent educational activities surrounding IRA Medicare drug price negotiation, interchangeable biosimilars, and other key policy issues affecting patient access to medicines. ASBM to Exhibit at ACR Convergence 2023 Visit ASBM at Booth #2612 at ACR Convergence in San Diego, CA, November 12-14th.